LABORATORY CORP OF AMERICA HOLDINGS Insider Trading for February 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in LABORATORY CORP OF AMERICA HOLDINGS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in LABORATORY CORP OF AMERICA HOLDINGS for February 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 14 2018 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Option Exercise | A | 168.49 | 41,000 | 6,908,090 | 41,000 | |
| Feb 14 2018 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Option Exercise | A | 0.00 | 10,540 | 0 | 32,601 | |
| Feb 14 2018 | LH | LABORATORY CORP OF ... | EISENBERG GLENN A | Chief Financial Off ... | Option Exercise | A | 0.00 | 2,340 | 0 | 10,831 | |
| Feb 14 2018 | LH | LABORATORY CORP OF ... | EISENBERG GLENN A | Chief Financial Off ... | Option Exercise | A | 168.49 | 9,100 | 1,533,259 | 9,100 | |
| Feb 14 2018 | LH | LABORATORY CORP OF ... | EISENBERG GLENN A | Chief Financial Off ... | Sell | S | 168.61 | 500 | 84,307 | 13,831 | 14.3 K to 13.8 K (-3.49 %) |
| Feb 14 2018 | LH | LABORATORY CORP OF ... | EISENBERG GLENN A | Chief Financial Off ... | Sell | S | 167.78 | 1,600 | 268,444 | 14,331 | 15.9 K to 14.3 K (-10.04 %) |
| Feb 14 2018 | LH | LABORATORY CORP OF ... | EISENBERG GLENN A | Chief Financial Off ... | Sell | S | 167.16 | 6,300 | 1,053,089 | 15,931 | 22.2 K to 15.9 K (-28.34 %) |
| Feb 14 2018 | LH | LABORATORY CORP OF ... | EBERTS F SAMUEL III | Chief Legal Officer ... | Option Exercise | A | 0.00 | 700 | 0 | 2,278 | |
| Feb 14 2018 | LH | LABORATORY CORP OF ... | EBERTS F SAMUEL III | Chief Legal Officer ... | Option Exercise | A | 168.49 | 2,700 | 454,923 | 2,700 | |
| Feb 14 2018 | LH | LABORATORY CORP OF ... | Uthgenannt Lisa J | Chief Human Resourc ... | Option Exercise | A | 0.00 | 770 | 0 | 2,565 | |
| Feb 14 2018 | LH | LABORATORY CORP OF ... | Uthgenannt Lisa J | Chief Human Resourc ... | Option Exercise | A | 168.49 | 3,000 | 505,470 | 3,000 | |
| Feb 14 2018 | LH | LABORATORY CORP OF ... | Ratliff John D | CEO, Covance Drug D ... | Option Exercise | A | 0.00 | 4,390 | 0 | 14,217 | |
| Feb 14 2018 | LH | LABORATORY CORP OF ... | Ratliff John D | CEO, Covance Drug D ... | Option Exercise | A | 168.49 | 17,100 | 2,881,179 | 17,100 | |
| Feb 14 2018 | LH | LABORATORY CORP OF ... | Dodson Edward T | Principal Accountin ... | Option Exercise | A | 0.00 | 590 | 0 | 1,934 | |
| Feb 14 2018 | LH | LABORATORY CORP OF ... | Dodson Edward T | Principal Accountin ... | Option Exercise | A | 168.49 | 2,300 | 387,527 | 2,300 | |
| Feb 14 2018 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Option Exercise | A | 0.00 | 700 | 0 | 5,191 | |
| Feb 14 2018 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Option Exercise | A | 168.49 | 2,700 | 454,923 | 2,700 | |
| Feb 14 2018 | LH | LABORATORY CORP OF ... | Gary M. Huff | CEO, LabCorp Diagno ... | Option Exercise | A | 0.00 | 1,760 | 0 | 14,721 | |
| Feb 14 2018 | LH | LABORATORY CORP OF ... | Gary M. Huff | CEO, LabCorp Diagno ... | Option Exercise | A | 168.49 | 6,800 | 1,145,732 | 6,800 | |
| Feb 14 2018 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Option Exercise | A | 0.00 | 1,038 | 0 | 1,038 | |
| Feb 14 2018 | LH | LABORATORY CORP OF ... | Schechter Adam H | Director | Option Exercise | A | 0.00 | 1,038 | 0 | 1,038 | |
| Feb 14 2018 | LH | LABORATORY CORP OF ... | Parham Richelle P | Director | Option Exercise | A | 0.00 | 1,038 | 0 | 1,038 | |
| Feb 14 2018 | LH | LABORATORY CORP OF ... | NEUPERT PETER M | Director | Option Exercise | A | 0.00 | 1,038 | 0 | 1,038 | |
| Feb 14 2018 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Option Exercise | A | 0.00 | 1,038 | 0 | 1,038 | |
| Feb 14 2018 | LH | LABORATORY CORP OF ... | Kong Garheng | Director | Option Exercise | A | 0.00 | 1,038 | 0 | 1,038 | |
| Feb 14 2018 | LH | LABORATORY CORP OF ... | Gilliland Dwight Gary | Director | Option Exercise | A | 0.00 | 1,038 | 0 | 1,038 | |
| Feb 14 2018 | LH | LABORATORY CORP OF ... | BELINGARD JEAN-LUC | Director | Option Exercise | A | 0.00 | 1,038 | 0 | 1,038 | |
| Feb 14 2018 | LH | LABORATORY CORP OF ... | ANDERSON KERRII B | Director | Option Exercise | A | 0.00 | 1,038 | 0 | 1,038 | |
| Feb 13 2018 | LH | LABORATORY CORP OF ... | Ratliff John D | CEO, Covance Drug D ... | Option Exercise | M | 0.00 | 6,100 | 0 | 9,827 | |
| Feb 13 2018 | LH | LABORATORY CORP OF ... | Ratliff John D | CEO, Covance Drug D ... | Payment of Exercise | F | 168.08 | 2,132 | 358,347 | 9,398 | 11.5 K to 9.4 K (-18.49 %) |
| Feb 13 2018 | LH | LABORATORY CORP OF ... | Ratliff John D | CEO, Covance Drug D ... | Buy | M | 0.00 | 6,100 | 0 | 11,530 | 5.4 K to 11.5 K (+112.34 %) |
| Feb 13 2018 | LH | LABORATORY CORP OF ... | ANDERSON KERRII B | Director | Option Exercise | M | 75.63 | 3,300 | 249,579 | 0 | |
| Feb 13 2018 | LH | LABORATORY CORP OF ... | ANDERSON KERRII B | Director | Sell | S | 166.10 | 3,300 | 548,124 | 18,095 | 21.4 K to 18.1 K (-15.42 %) |
| Feb 13 2018 | LH | LABORATORY CORP OF ... | ANDERSON KERRII B | Director | Buy | M | 75.63 | 3,300 | 249,579 | 21,395 | 18.1 K to 21.4 K (+18.24 %) |
| Feb 13 2018 | LH | LABORATORY CORP OF ... | EISENBERG GLENN A | Chief Financial Off ... | Option Exercise | M | 0.00 | 3,047 | 0 | 8,491 | |
| Feb 13 2018 | LH | LABORATORY CORP OF ... | EISENBERG GLENN A | Chief Financial Off ... | Option Exercise | M | 0.00 | 1,830 | 0 | 11,538 | |
| Feb 13 2018 | LH | LABORATORY CORP OF ... | EISENBERG GLENN A | Chief Financial Off ... | Payment of Exercise | F | 168.08 | 913 | 153,457 | 22,231 | 23.1 K to 22.2 K (-3.94 %) |
| Feb 13 2018 | LH | LABORATORY CORP OF ... | EISENBERG GLENN A | Chief Financial Off ... | Buy | M | 0.00 | 3,047 | 0 | 23,144 | 20.1 K to 23.1 K (+15.16 %) |
| Feb 13 2018 | LH | LABORATORY CORP OF ... | EISENBERG GLENN A | Chief Financial Off ... | Payment of Exercise | F | 168.08 | 549 | 92,276 | 20,097 | 20.6 K to 20.1 K (-2.66 %) |
| Feb 13 2018 | LH | LABORATORY CORP OF ... | EISENBERG GLENN A | Chief Financial Off ... | Buy | M | 0.00 | 1,830 | 0 | 20,646 | 18.8 K to 20.6 K (+9.73 %) |
| Feb 13 2018 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Option Exercise | M | 0.00 | 3,047 | 0 | 4,491 | |
| Feb 13 2018 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Option Exercise | M | 0.00 | 450 | 0 | 7,538 | |
| Feb 13 2018 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Payment of Exercise | F | 168.08 | 913 | 153,457 | 8,429 | 9.3 K to 8.4 K (-9.77 %) |
| Feb 13 2018 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Buy | M | 0.00 | 3,047 | 0 | 9,342 | 6.3 K to 9.3 K (+48.40 %) |
| Feb 13 2018 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Payment of Exercise | F | 168.08 | 135 | 22,691 | 6,295 | 6.4 K to 6.3 K (-2.10 %) |
| Feb 13 2018 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Buy | M | 0.00 | 450 | 0 | 6,430 | 6 K to 6.4 K (+7.53 %) |
| Feb 13 2018 | LH | LABORATORY CORP OF ... | Dodson Edward T | Principal Accountin ... | Option Exercise | M | 0.00 | 450 | 0 | 1,344 | |
| Feb 13 2018 | LH | LABORATORY CORP OF ... | Dodson Edward T | Principal Accountin ... | Payment of Exercise | F | 168.08 | 167 | 28,069 | 5,506 | 5.7 K to 5.5 K (-2.94 %) |
| Feb 13 2018 | LH | LABORATORY CORP OF ... | Dodson Edward T | Principal Accountin ... | Buy | M | 0.00 | 450 | 0 | 5,673 | 5.2 K to 5.7 K (+8.62 %) |
| Feb 13 2018 | LH | LABORATORY CORP OF ... | EBERTS F SAMUEL III | Chief Legal Officer ... | Option Exercise | M | 0.00 | 520 | 0 | 1,578 | |
| Feb 13 2018 | LH | LABORATORY CORP OF ... | EBERTS F SAMUEL III | Chief Legal Officer ... | Payment of Exercise | F | 168.08 | 144 | 24,204 | 24,284 | 24.4 K to 24.3 K (-0.59 %) |
| Feb 13 2018 | LH | LABORATORY CORP OF ... | EBERTS F SAMUEL III | Chief Legal Officer ... | Buy | M | 0.00 | 520 | 0 | 24,428 | 23.9 K to 24.4 K (+2.18 %) |
| Feb 13 2018 | LH | LABORATORY CORP OF ... | Uthgenannt Lisa J | Chief Human Resourc ... | Option Exercise | M | 0.00 | 603 | 0 | 1,795 | |
| Feb 13 2018 | LH | LABORATORY CORP OF ... | Uthgenannt Lisa J | Chief Human Resourc ... | Payment of Exercise | F | 168.08 | 203 | 34,120 | 4,237 | 4.4 K to 4.2 K (-4.57 %) |
| Feb 13 2018 | LH | LABORATORY CORP OF ... | Uthgenannt Lisa J | Chief Human Resourc ... | Buy | M | 0.00 | 603 | 0 | 4,440 | 3.8 K to 4.4 K (+15.72 %) |
| Feb 13 2018 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Option Exercise | M | 0.00 | 7,543 | 0 | 22,061 | |
| Feb 13 2018 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Payment of Exercise | F | 168.08 | 3,138 | 527,435 | 177,890 | 181 K to 177.9 K (-1.73 %) |
| Feb 13 2018 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Buy | M | 0.00 | 7,543 | 0 | 181,028 | 173.5 K to 181 K (+4.35 %) |
| Feb 09 2018 | LH | LABORATORY CORP OF ... | Uthgenannt Lisa J | Chief Human Resourc ... | Option Exercise | M | 0.00 | 326 | 0 | 2,398 | |
| Feb 09 2018 | LH | LABORATORY CORP OF ... | Uthgenannt Lisa J | Chief Human Resourc ... | Payment of Exercise | F | 169.66 | 129 | 21,886 | 3,837 | 4 K to 3.8 K (-3.25 %) |
| Feb 09 2018 | LH | LABORATORY CORP OF ... | Uthgenannt Lisa J | Chief Human Resourc ... | Buy | M | 0.00 | 326 | 0 | 3,966 | 3.6 K to 4 K (+8.96 %) |
| Feb 09 2018 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Option Exercise | M | 0.00 | 4,220 | 0 | 29,604 | |
| Feb 09 2018 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Payment of Exercise | F | 169.66 | 1,264 | 214,450 | 173,485 | 174.7 K to 173.5 K (-0.72 %) |
| Feb 09 2018 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Buy | M | 0.00 | 4,220 | 0 | 174,749 | 170.5 K to 174.7 K (+2.47 %) |
| Feb 09 2018 | LH | LABORATORY CORP OF ... | Ratliff John D | CEO, Covance Drug D ... | Option Exercise | M | 0.00 | 1,863 | 0 | 15,927 | |
| Feb 09 2018 | LH | LABORATORY CORP OF ... | Ratliff John D | CEO, Covance Drug D ... | Payment of Exercise | F | 169.66 | 560 | 95,010 | 5,430 | 6 K to 5.4 K (-9.35 %) |
| Feb 09 2018 | LH | LABORATORY CORP OF ... | Ratliff John D | CEO, Covance Drug D ... | Buy | M | 0.00 | 1,863 | 0 | 5,990 | 4.1 K to 6 K (+45.14 %) |
| Feb 09 2018 | LH | LABORATORY CORP OF ... | Gary M. Huff | CEO, LabCorp Diagno ... | Option Exercise | M | 0.00 | 630 | 0 | 12,961 | |
| Feb 09 2018 | LH | LABORATORY CORP OF ... | Gary M. Huff | CEO, LabCorp Diagno ... | Option Exercise | M | 0.00 | 446 | 0 | 13,591 | |
| Feb 09 2018 | LH | LABORATORY CORP OF ... | Gary M. Huff | CEO, LabCorp Diagno ... | Payment of Exercise | F | 169.66 | 188 | 31,896 | 1,096 | 1.3 K to 1.1 K (-14.64 %) |
| Feb 09 2018 | LH | LABORATORY CORP OF ... | Gary M. Huff | CEO, LabCorp Diagno ... | Buy | M | 0.00 | 630 | 0 | 1,284 | 654 to 1.3 K (+96.33 %) |
| Feb 09 2018 | LH | LABORATORY CORP OF ... | Gary M. Huff | CEO, LabCorp Diagno ... | Payment of Exercise | F | 169.66 | 141 | 23,922 | 654 | 795 to 654 (-17.74 %) |
| Feb 09 2018 | LH | LABORATORY CORP OF ... | Gary M. Huff | CEO, LabCorp Diagno ... | Buy | M | 0.00 | 446 | 0 | 795 | 349 to 795 (+127.79 %) |
| Feb 09 2018 | LH | LABORATORY CORP OF ... | EISENBERG GLENN A | Chief Financial Off ... | Option Exercise | M | 0.00 | 993 | 0 | 13,368 | |
| Feb 09 2018 | LH | LABORATORY CORP OF ... | EISENBERG GLENN A | Chief Financial Off ... | Payment of Exercise | F | 169.66 | 299 | 50,728 | 18,816 | 19.1 K to 18.8 K (-1.56 %) |
| Feb 09 2018 | LH | LABORATORY CORP OF ... | EISENBERG GLENN A | Chief Financial Off ... | Buy | M | 0.00 | 993 | 0 | 19,115 | 18.1 K to 19.1 K (+5.48 %) |
| Feb 09 2018 | LH | LABORATORY CORP OF ... | EBERTS F SAMUEL III | Chief Legal Officer ... | Option Exercise | M | 0.00 | 296 | 0 | 2,098 | |
| Feb 09 2018 | LH | LABORATORY CORP OF ... | EBERTS F SAMUEL III | Chief Legal Officer ... | Payment of Exercise | F | 169.66 | 82 | 13,912 | 23,908 | 24 K to 23.9 K (-0.34 %) |
| Feb 09 2018 | LH | LABORATORY CORP OF ... | EBERTS F SAMUEL III | Chief Legal Officer ... | Buy | M | 0.00 | 296 | 0 | 23,990 | 23.7 K to 24 K (+1.25 %) |
| Feb 09 2018 | LH | LABORATORY CORP OF ... | Dodson Edward T | Principal Accountin ... | Option Exercise | M | 0.00 | 246 | 0 | 1,794 | |
| Feb 09 2018 | LH | LABORATORY CORP OF ... | Dodson Edward T | Principal Accountin ... | Payment of Exercise | F | 169.66 | 92 | 15,609 | 5,223 | 5.3 K to 5.2 K (-1.73 %) |
| Feb 09 2018 | LH | LABORATORY CORP OF ... | Dodson Edward T | Principal Accountin ... | Buy | M | 0.00 | 246 | 0 | 5,315 | 5.1 K to 5.3 K (+4.85 %) |
| Feb 09 2018 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Option Exercise | M | 0.00 | 296 | 0 | 7,988 | |
| Feb 09 2018 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Payment of Exercise | F | 169.66 | 105 | 17,814 | 5,980 | 6.1 K to 6 K (-1.73 %) |
| Feb 09 2018 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Buy | M | 0.00 | 296 | 0 | 6,085 | 5.8 K to 6.1 K (+5.11 %) |
| Feb 09 2018 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Option Exercise | M | 0.00 | 1,263 | 0 | 0 | |
| Feb 09 2018 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Buy | M | 0.00 | 1,263 | 0 | 8,236 | 7 K to 8.2 K (+18.11 %) |
| Feb 09 2018 | LH | LABORATORY CORP OF ... | Schechter Adam H | Director | Option Exercise | M | 0.00 | 1,263 | 0 | 0 | |
| Feb 09 2018 | LH | LABORATORY CORP OF ... | Schechter Adam H | Director | Sell | S | 169.29 | 1,263 | 213,813 | 6,034 | 7.3 K to 6 K (-17.31 %) |
| Feb 09 2018 | LH | LABORATORY CORP OF ... | Schechter Adam H | Director | Buy | M | 0.00 | 1,263 | 0 | 7,297 | 6 K to 7.3 K (+20.93 %) |
| Feb 09 2018 | LH | LABORATORY CORP OF ... | Parham Richelle P | Director | Option Exercise | M | 0.00 | 1,263 | 0 | 0 | |
| Feb 09 2018 | LH | LABORATORY CORP OF ... | Parham Richelle P | Director | Buy | M | 0.00 | 1,263 | 0 | 2,823 | 1.6 K to 2.8 K (+80.96 %) |
| Feb 09 2018 | LH | LABORATORY CORP OF ... | NEUPERT PETER M | Director | Option Exercise | M | 0.00 | 1,263 | 0 | 0 | |
| Feb 09 2018 | LH | LABORATORY CORP OF ... | NEUPERT PETER M | Director | Buy | M | 0.00 | 1,263 | 0 | 7,731 | 6.5 K to 7.7 K (+19.53 %) |
| Feb 09 2018 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Option Exercise | M | 0.00 | 1,263 | 0 | 0 | |
| Feb 09 2018 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Buy | M | 0.00 | 1,263 | 0 | 14,171 | 12.9 K to 14.2 K (+9.78 %) |
| Feb 09 2018 | LH | LABORATORY CORP OF ... | Kong Garheng | Director | Option Exercise | M | 0.00 | 1,263 | 0 | 0 | |
| Feb 09 2018 | LH | LABORATORY CORP OF ... | Kong Garheng | Director | Buy | M | 0.00 | 1,263 | 0 | 6,187 | 4.9 K to 6.2 K (+25.65 %) |
| Feb 09 2018 | LH | LABORATORY CORP OF ... | Gilliland Dwight Gary | Director | Option Exercise | M | 0.00 | 1,263 | 0 | 0 | |
| Feb 09 2018 | LH | LABORATORY CORP OF ... | Gilliland Dwight Gary | Director | Buy | M | 0.00 | 1,263 | 0 | 4,764 | 3.5 K to 4.8 K (+36.08 %) |
| Feb 09 2018 | LH | LABORATORY CORP OF ... | BELINGARD JEAN-LUC | Director | Option Exercise | M | 0.00 | 1,263 | 0 | 0 | |
| Feb 09 2018 | LH | LABORATORY CORP OF ... | BELINGARD JEAN-LUC | Director | Payment of Exercise | F | 169.66 | 127 | 21,547 | 33,079 | 33.2 K to 33.1 K (-0.38 %) |
| Feb 09 2018 | LH | LABORATORY CORP OF ... | BELINGARD JEAN-LUC | Director | Buy | M | 0.00 | 1,263 | 0 | 33,206 | 31.9 K to 33.2 K (+3.95 %) |
| Feb 09 2018 | LH | LABORATORY CORP OF ... | ANDERSON KERRII B | Director | Option Exercise | M | 0.00 | 1,263 | 0 | 0 | |
| Feb 09 2018 | LH | LABORATORY CORP OF ... | ANDERSON KERRII B | Director | Buy | M | 0.00 | 1,263 | 0 | 18,095 | 16.8 K to 18.1 K (+7.50 %) |